实用老年医学 ›› 2026, Vol. 40 ›› Issue (9): 935-940.doi: 10.3969/j.issn.1003-9198.2026.09.014

• 临床研究 • 上一篇    下一篇

移动肺康复装置在老年慢性阻塞性肺疾病合并缺血性心脏病患者中的应用效果评价

李俊芝, 杜毓锋   

  1. 030001 山西省太原市,山西医科大学第一临床医学院(李俊芝);
    030001 山西省太原市,山西医科大学第一医院老年病二科(杜毓锋)
  • 收稿日期:2026-02-02 出版日期:2026-09-20 发布日期:2026-09-16
  • 通讯作者: 杜毓锋,Email:yufengdu0126@163.com
  • 基金资助:
    山西省知识产权局专利转化计划项目(202406006)

Evaluation of the effectiveness of mobile pulmonary rehabilitation devices in elderly patients with chronic obstructive pulmonary disease complicated with ischemic heart disease

LI Junzhi, DU Yufeng   

  1. The First Clinical Medical College of Shanxi Medical University, Taiyuan 030001, China(LI Junzhi);
    Department of Geriatric Medicine Ⅱ, the First Affiliated Hospital of Shanxi Medical University, Taiyuan 030001, China(DU Yufeng)
  • Received:2026-02-02 Online:2026-09-20 Published:2026-09-16
  • Contact: DU Yufeng, Email: yufengdu0126@163.com

摘要: 目的 探讨基于移动健康装置的肺康复对COPD合并缺血性心脏病患者的临床效果、依从性及安全性。方法 采用前瞻性研究方法,纳入70例COPD合并缺血性心脏病患者,按照随机数表法分为对照组(35例)和试验组(35例)。在常规治疗基础上,对照组进行12周自主肺康复训练,试验组接受12周基于移动肺康复装置的肺康复训练。比较2组干预前后肺功能指标(FEV1、FVC、FEV1/FVC、FEV1%pred)、握力、6 min步行距离(6MWD),评估2组干预前后Berg平衡量表(BBS)、COPD患者自我评估测试(CAT)、西雅图心绞痛量表(SAQ)、汉密尔顿焦虑量表(HAMA)、汉密尔顿抑郁量表(HAMD)评分情况,并观察依从性及安全性。结果 68例患者完成本次研究,其中对照组33例,试验组35例。试验组干预后FEV1、FEV1/FVC、FEV1%pred、握力、6MWD以及BBS、CAT、SAQ、HAMA、HAMD评分与干预前比较明显改善,差异均有统计学意义(P<0.05),对照组干预后握力、6MWD、SAQ评分较干预前差异有统计学意义(P<0.05);干预后试验组6MWD明显长于对照组,治疗依从性更高,差异均有统计学意义(P<0.05)。2组在研究过程中均未出现与训练相关的不良反应。结论 基于移动健康装置的肺康复有助于改善COPD合并缺血性心脏病患者的运动耐量,提高运动依从性,且安全性良好,是一种安全有效的康复策略。

关键词: 老年人, 慢性阻塞性肺疾病, 缺血性心脏病, 肺康复, 移动装置

Abstract: Objective To investigate the clinical efficacy, compliance, and safety of pulmonary rehabilitation based on mobile health devices in the elderly patients with chronic obstructive pulmonary disease (COPD) complicated with ischemic heart disease. Methods A prospective study was carried out in 70 patients with COPD complicated with ischemic heart disease. The patients were randomly divided into a control group (n=35) and a experimental group (n=35) using a random number table. In addition to conventional treatment, the two groups underwent different interventions: the control group received 12 weeks of self-directed pulmonary rehabilitation training, while the experimental group received 12 weeks of pulmonary rehabilitation training using a mobile pulmonary rehabilitation device. The pulmonary function indicators, such as forced expiratory volume in one second (FEV1), forced vital capacity (FVC), FEV1/FVC, percentage of predicted forced expiratory volume in one second (FEV1%pred), and grip strength, 6-minute walk distance (6MWD) of the two groups were observed and compared. The scores of Berg Balance Scale(BBS), COPD Assessment Test (CAT), Seattle Angina Questionnaire (SAQ), Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD) were assessed, and training compliance and safety were observed and compared between the two groups before and after the intervention. Results After intervention, the experimental group showed significant improvements in FEV1, FEV1/FVC, FEV1%pred, grip strength, 6MWD, and scores of the BBS, CAT, SAQ, HAMA, and HAMD scales compared to baseline, with all differences being statistically significant (P<0.05). In the control group, grip strength, 6MWD and SAQ scores also exhibited statistically significant improvements post-intervention (P<0.05). The experimental group demonstrated significantly longer 6MWD and higher treatment adherence than those of the control group, with significant difference (P<0.05). No training-related adverse reactions were reported in either group during the study. Conclusions Pulmonary rehabilitation using mobile health devices effectively enhances exercise tolerance and improves treatment adherence in COPD patients with ischemic heart disease.

Key words: aged, chronic obstructive pulmonary disease, ischemic heart disease, pulmonary rehabilitation, mobile device

中图分类号: